8-K: Akoustis Technologies Secures $10 Million in Registered Direct Offering
Capital Raise Announcement
Akoustis Technologies has entered into a securities purchase agreement to raise approximately $10 million through a registered direct offering of common stock and pre-funded warrants.
Summary
- Akoustis Technologies, Inc. has agreed to sell 10,500,000 shares of its common stock and pre-funded warrants to purchase up to 39,500,000 shares in a registered direct offering.
- The offering price was $0.20 per share and $0.199 per pre-funded warrant.
- The pre-funded warrants have an exercise price of $0.001 per share and are exercisable immediately.
- The gross proceeds from the offering are approximately $10 million, before deducting fees and expenses.
- The company intends to use the net proceeds for working capital and to fund its operations.
- Roth Capital Partners, LLC acted as the placement agent for the offering and received a 6% cash fee of the gross proceeds and reimbursement for up to $50,000 of expenses.
- The closing of the offering occurred on May 24, 2024.
Sentiment
Score: 6
Explanation: The document indicates a necessary capital raise, which is positive for the company's ability to continue operations, but the terms of the offering, including the low share price and potential dilution, temper the overall sentiment.
Positives
- The company successfully raised $10 million in gross proceeds.
- The pre-funded warrants provide an immediate source of potential future capital.
- The funds will be used for working capital and operations, supporting the company's growth.
- The offering was completed quickly, closing on May 24, 2024.
Negatives
- The offering involved the issuance of a significant number of new shares, potentially diluting existing shareholders.
- The company incurred placement agent fees of 6% of the gross proceeds, plus up to $50,000 in expenses.
- The offering price of $0.20 per share may be considered low, potentially indicating a need for capital at a lower valuation.
Risks
- The issuance of a large number of shares could dilute existing shareholders.
- The company's reliance on this capital raise may indicate financial challenges.
- The pre-funded warrants could lead to further dilution if exercised.
- The company's ability to effectively use the funds for working capital and operations is crucial for future success.
Future Outlook
The company intends to use the net proceeds from the offering for working capital and to fund its operations.
Industry Context
This capital raise is a common method for technology companies to secure funding for operations and growth. The use of pre-funded warrants is a strategy to attract investors while providing flexibility for future capital needs.
Comparison to Industry Standards
- The use of a registered direct offering is a fairly standard method for raising capital, particularly for companies that already have a shelf registration in place.
- The 6% placement agent fee is within the typical range for such transactions, although it can vary based on the size and complexity of the offering.
- The offering price of $0.20 per share is relatively low, which may indicate that the company needed to raise capital quickly and was willing to accept a lower valuation.
- Comparable companies in the technology sector often use similar methods to raise capital, including private placements, follow-on offerings, and debt financing.
Stakeholder Impact
- Shareholders may experience dilution due to the issuance of new shares.
- Employees may benefit from the company's improved financial position.
- Customers and suppliers may see continued operations and potential growth.
- Creditors may have increased confidence in the company's ability to meet its obligations.
Next Steps
- The company will use the net proceeds for working capital and operations.
- The company will need to manage the potential dilution from the new shares and pre-funded warrants.
- The company will need to execute its business plan to demonstrate the value of the capital raise.
Key Dates
| Date | Description |
|---|---|
| 2022-02-04 | Shelf registration statement on Form S-3 filed with the SEC. |
| 2022-02-15 | Shelf registration statement declared effective by the SEC. |
| 2024-05-22 | Date of the securities purchase agreement and placement agency agreement. |
| 2024-05-24 | Closing date of the registered direct offering. |
Keywords
registered direct offering, common stock, pre-funded warrants, capital raise, placement agent, working capital, dilution, Akoustis Technologies, securities purchase agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.